Skip to main content
Caplight Logo









Neuromedical

Neuromedical

Private
PolandHealthcare & Life Scienceshttps://neuromedical.pl/

Last Round

Seed

Feb 17, 2026

Total Funding Raised

$2.58M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Neuromedical is a medical device company that develops VGuard, a non-invasive transcutaneous vagus nerve stimulation system designed for the treatment of mild cognitive impairment and early-stage Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2B2C

Customer Profile

Hardware + Subscription

AI Layer

Non-AI

Keywords

neuromodulationtranscutaneous vagus nerve stimulationtVNSAlzheimer's treatmentmild cognitive impairmentMCIat-home therapyhardware-as-a-serviceHaaSmedical devicedigital healthremote patient monitoringbrain techneurotechnon-invasive stimulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuromedical Comparables

Compare Neuromedical with similar companies based on industry and business-model similarity.

Neuromedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
tVNS Technologies GmbH
78%
Cognito Therapeutics
74%
Vagustim
66%

Neuromedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 17, 2026
SeedMay 20, 2025
SeedMay 17, 2020

Neuromedical Investors

Notable investors and investment history

Neuromedical investors
InvestorRounds
INNOventureSeed
Hard2beatSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 18, 2026

    Raised $1.54M in a Seed round.

Neuromedical Filings

Explore SEC and related filing metadata, where available.

Neuromedical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neuromedical's valuation, stock price, and market status.

Is Neuromedical a public or private company?

Neuromedical is a private company.

What is the current stock price of Neuromedical?

Neuromedical is a private company with no public stock price. No recent secondary market data is available.

How much is Neuromedical worth (valuation)?

Valuation information for Neuromedical is not publicly available.

Can I buy Neuromedical stock?

Neuromedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neuromedical's last funding round?

Neuromedical's most recent funding round was Seed on February 18, 2026.

Who are the main investors in Neuromedical?

Key investors in Neuromedical include Hard2beat.

Will Neuromedical IPO soon?

No public IPO plans have been announced for Neuromedical.

How can I track Neuromedical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neuromedical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPoland
Employee Range-
Year Founded2016
Last FundingFeb 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?